The Wavelia Microwave Breast Imaging system-tumour discriminating features and their clinical usefulness.

ABSTRACT:

Objective

The Wavelia Microwave Breast Imaging (MBI) system, based on non-ionising imaging technology, has demonstrated exciting potential in the detection and localisation of breast pathology in symptomatic patients. In this study, the ability of the system to accurately estimate the size and likelihood of malignancy of breast lesions is detailed, and its clinical usefulness determined.

Methods

Institutional review board and Health Products Regulatory Authority (HPRA) approval were obtained. Patients were recruited from the symptomatic unit to three groups; breast cancer (Group-1), unaspirated cysts (Group-2) and biopsied benign lesions (Group-3). MBI, radiological and histopathological findings were reviewed. MBI size estimations were compared with the sizes determined by

SUBMITTER: Moloney BM 

PROVIDER: S-EPMC8631021 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature